Gyon Technologies Capital Management, LP Horizon Therapeutics Public LTD CO Transaction History

Gyon Technologies Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $364,843 - $534,674	4,595 Added 204.95%	6,837 $545,000
Q1 2022 May 12, 2022	SELL	$86.42 - $109.81 $600,878 - $763,508	-6,953 Reduced 75.62%	2,242 $236,000
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $551,246 - $670,656	5,593 Added 155.27%	9,195 $991,000
Q3 2021 Nov 18, 2021	BUY	$91.91 - $110.37 $331,059 - $397,552	3,602 New	3,602 $395,000
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $356,492 - $473,867	-4,963 Closed	0 $0

Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $332,521 - $418,827	4,963 New	4,963 $363,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.